Celltrion, Foreign Investors Net Buy 200,642 Shares in Last 5 Days... Stock Price 257,000 Won (-0.19%)

As of 2:33 PM on the 5th, Celltrion is trading at 257,000 KRW, down 0.19% from the previous day. The trading volume is 514,884 shares, which is about 81.14% of the previous day's volume. Celltrion is known as a protein and biopharmaceutical manufacturing company.

On September 28, analyst Kang Ha-young of KTB Investment & Securities stated, "The merger of the three companies will proceed depending on the results of the shareholders' meeting. Celltrion, Celltrion Healthcare, and Celltrion Pharm are listed companies, and the merger of the three companies will be decided based on a special resolution at the shareholders' meeting. The merger will be approved if more than one-third of the total issued shares and two-thirds of the voting rights of attending shareholders agree. Regarding the merger ratio, it is calculated by weighted averaging the stock prices one day, one week, and one month before the board resolution on the merger, but some adjustments are possible. The target and method of the merger are still undecided." He set Celltrion's target price at 290,000 KRW.

Over the past five days, individual investors have net sold 33,945 shares of Celltrion, while foreigners and institutions have net bought 200,642 shares and net sold 158,490 shares, respectively.

※ Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.